Cargando…
No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands
In two Dutch observational cohorts of people with HIV, the use of TDF, ETR, or INSTIs was not independently associated with either the risk of incident SARS-CoV-2 infection or severe COVID-19 outcomes, as was suggested by previous observational and molecular docking studies. Our findings do not supp...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328501/ https://www.ncbi.nlm.nih.gov/pubmed/37395254 http://dx.doi.org/10.1097/QAD.0000000000003577 |
_version_ | 1785069811829571584 |
---|---|
author | Verburgh, Myrthe L. van der Valk, Marc Rijnders, Bart J.A. Reiss, Peter Wit, Ferdinand W.N.M. |
author_facet | Verburgh, Myrthe L. van der Valk, Marc Rijnders, Bart J.A. Reiss, Peter Wit, Ferdinand W.N.M. |
author_sort | Verburgh, Myrthe L. |
collection | PubMed |
description | In two Dutch observational cohorts of people with HIV, the use of TDF, ETR, or INSTIs was not independently associated with either the risk of incident SARS-CoV-2 infection or severe COVID-19 outcomes, as was suggested by previous observational and molecular docking studies. Our findings do not support a strategy of modifying antiretroviral therapy to include these agents to protect against SARS-CoV-2 infection and severe COVID-19 outcomes. |
format | Online Article Text |
id | pubmed-10328501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-103285012023-07-08 No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands Verburgh, Myrthe L. van der Valk, Marc Rijnders, Bart J.A. Reiss, Peter Wit, Ferdinand W.N.M. AIDS Research Letters In two Dutch observational cohorts of people with HIV, the use of TDF, ETR, or INSTIs was not independently associated with either the risk of incident SARS-CoV-2 infection or severe COVID-19 outcomes, as was suggested by previous observational and molecular docking studies. Our findings do not support a strategy of modifying antiretroviral therapy to include these agents to protect against SARS-CoV-2 infection and severe COVID-19 outcomes. Lippincott Williams & Wilkins 2023-07-15 2023-04-13 /pmc/articles/PMC10328501/ /pubmed/37395254 http://dx.doi.org/10.1097/QAD.0000000000003577 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) |
spellingShingle | Research Letters Verburgh, Myrthe L. van der Valk, Marc Rijnders, Bart J.A. Reiss, Peter Wit, Ferdinand W.N.M. No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands |
title | No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands |
title_full | No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands |
title_fullStr | No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands |
title_full_unstemmed | No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands |
title_short | No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands |
title_sort | no association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of sars-cov-2 infection in people with hiv in the netherlands |
topic | Research Letters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328501/ https://www.ncbi.nlm.nih.gov/pubmed/37395254 http://dx.doi.org/10.1097/QAD.0000000000003577 |
work_keys_str_mv | AT verburghmyrthel noassociationbetweenuseoftenofovirdisoproxilfumarateetravirineorintegrasestrandtransferinhibitorsandacquisitionorsevereoutcomesofsarscov2infectioninpeoplewithhivinthenetherlands AT vandervalkmarc noassociationbetweenuseoftenofovirdisoproxilfumarateetravirineorintegrasestrandtransferinhibitorsandacquisitionorsevereoutcomesofsarscov2infectioninpeoplewithhivinthenetherlands AT rijndersbartja noassociationbetweenuseoftenofovirdisoproxilfumarateetravirineorintegrasestrandtransferinhibitorsandacquisitionorsevereoutcomesofsarscov2infectioninpeoplewithhivinthenetherlands AT reisspeter noassociationbetweenuseoftenofovirdisoproxilfumarateetravirineorintegrasestrandtransferinhibitorsandacquisitionorsevereoutcomesofsarscov2infectioninpeoplewithhivinthenetherlands AT witferdinandwnm noassociationbetweenuseoftenofovirdisoproxilfumarateetravirineorintegrasestrandtransferinhibitorsandacquisitionorsevereoutcomesofsarscov2infectioninpeoplewithhivinthenetherlands |